Welcome to LookChem.com Sign In|Join Free
  • or
Benzenesulfonamide, N-(2-methylpropyl)-3-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

89840-73-3

Post Buying Request

89840-73-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89840-73-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 89840-73-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,8,4 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 89840-73:
(7*8)+(6*9)+(5*8)+(4*4)+(3*0)+(2*7)+(1*3)=183
183 % 10 = 3
So 89840-73-3 is a valid CAS Registry Number.

89840-73-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(2-methylpropyl)-3-nitrobenzenesulfonamide

1.2 Other means of identification

Product number -
Other names N-isobutyl-3-nitrobenzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89840-73-3 SDS

89840-73-3Downstream Products

89840-73-3Relevant academic research and scientific papers

SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE

-

, (2008/06/13)

This invention provides a novel class of sulfonamide compounds of formula I which are aspartyl protease inhibitors: STR1 This invention also provides pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also provides methods for inhibition aspartyl protease activity and methods for treating viral infections using the compounds and compositions of this invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 89840-73-3